Skip to main content

Samsung invests in Chicago biotech Jaguar Gene Therapy

The cash will help Jaguar advance its preclinical pipeline of therapies that target type 1 diabetes, galactosemia, autism spectrum disorder and other genetic conditions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.